• WATSON PHARMACEUTICALS INC Income Statement

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY2003
    Net Sales/Revenues 2.50 B 1.98 B 1.65 B 1.64 B 1.44 B
    Cost of Goods Sold (Excluding Depreciation) 1.43 B 1.18 B 809.63 M 786.42 M 596.17 M
    Depreciation, Depletion and Amortization 253.56 M 218.35 M 206.73 M 106.67 M 100.35 M
    Gross Income 815.49 M 582.05 M 629.85 M 747.47 M 740.20 M
    Selling, General & Admin Expenses 499.64 M 436.08 M 386.26 M 435.43 M 422.28 M
    Other Operating Expense 0.00 0.00 0.00 0.00 0.00
    Operating Expenses - Total 160.82 M 238.82 M 103.36 M 91.84 M 82.69 M
    Operating Income 315.84 M 145.97 M 243.59 M 312.04 M 317.91 M
    Extraordinary Credit - Pretax 6.12 M 0.00 0.00 0.00 36.68 M
    Extraordinary Charge - Pretax 71.85 M 568.59 M 25.08 M 71.71 M 38.71 M
    Non-operating Interest Income 8.89 M 28.42 M 19.32 M 6.62 M 5.51 M
    Reserves Inc (Dec) 0.00 0.00 0.00 0.00 0.00
    Pretax Equity in Earnings 0.00 0.00 0.00 0.00
    Other Income/Expenses - Net 2.25 M 3.27 M -1.03 M 8.53 M 23.81 M
    Earnings Before Interest & Taxes (EBIT) 261.25 M -390.93 M 236.80 M 255.48 M 345.19 M
    Interest Expenses On Debt 44.47 M 22.08 M 14.52 M 15.23 M 27.41 M
    Interest Capitalized 1.90 M 1.60 M
    Pretax Income 216.77 M -413.02 M 222.28 M 242.15 M 319.39 M
    Income Taxes 83.25 M 34.06 M 81.18 M 85.54 M 115.25 M
    Current Domestic Income Tax 89.26 M 57.17 M 86.54 M 72.08 M 145.49 M
    Current Foreign Income Tax 240,000.00 1.58 M 0.00 0.00 0.00
    Deferred Domestic Income Tax -8.16 M -23.55 M -5.36 M 13.46 M -30.24 M
    Deferred Foreign Income Tax 1.91 M -1.14 M 0.00 0.00 0.00
    Income Tax Credits
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Equity in Earnings 7.51 M 2.07 M -2.86 M -6.58 M -1.27 M
    After Tax Income Expense 0.00 0.00 0.00 0.00 0.00
    Discontinued Operations 0.00 0.00 0.00 0.00 0.00
    Net Income Before Extra Items/Preferred Div 141.03 M -445.00 M 138.23 M 150.02 M 202.86 M
    Extra Items & Gain (Loss) Sale of Assets 0.00 0.00 0.00 0.00 0.00
    Net Income Before Preferred Dividends 141.03 M -445.00 M 138.23 M 150.02 M 202.86 M
    Preferred Dividend Requirements 0.00 0.00 0.00 0.00 0.00
    Net Income Available to Common 148.81 M -445.00 M 145.71 M 156.61 M 202.86 M